Niiki Pharma, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2007-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://niikipharma.com
Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors
- First Posted Date
- 2011-08-11
- Last Posted Date
- 2017-05-19
- Lead Sponsor
- Niiki Pharma Inc.
- Target Recruit Count
- 46
- Registration Number
- NCT01415297
- Locations
- 🇺🇸
TGEN Clinical Research Services at Scottsdale Healthcare, Scottsdale, Arizona, United States
🇺🇸The Sarah Cannon Research Institute, Nashville, Tennessee, United States
© Copyright 2025. All Rights Reserved by MedPath